Las Vegas Sands

Showing 3483 articles
Business

AbCellera Biologics: A Tale of Two Valuations Amid Steep Share Decline

Shares of antibody discovery firm AbCellera Biologics plunged 16.8% last week, reigniting debate over its true worth. While a discounted cash flow model suggests deep undervaluation, its sky-high price-to-sales ratio paints a starkly different picture, leaving investors to navigate conflicting signals in a volatile biotech market.

Business

Beyond the Headlines: Puget Sound's Tech Shake-Up Tests Regional Resilience

As major tech firms announce significant layoffs across Washington, the region grapples with a fundamental question: Is this a temporary downturn or a structural pivot toward AI and new industries? The impact ripples far beyond corporate campuses, threatening the vitality of local small businesses that built their models on tech's explosive growth.